Phathom Pharmaceuticals Inc.

PHAT | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.45

-$0.03 (-0.40%)

At close: Sep 21, 2026, 4:00 PM ET

$7.67

+$0.22 (+3.00%)

Pre-market: Sep 22, 2026, 7:41 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-221.25M	-334.33M	-201.59M	-197.72M	-143.88M	-129.07M
Depreciation & Amortization	633K	795K	575K	620K	521K	323K
Stock-Based Compensation	28.72M	24.05M	45.03M	24.13M	16.81M	5.84M
Other Working Capital	4.63M	-6.93M	-8.98M	-3.24M	-17.52M	27.71M
Other Non-Cash Items	37.5M	58.01M	32.06M	21M	5.41M	1.5M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-12.38M	-15.3M	-13.64M	5.44M	-27.32M	51.72M
Operating Cash Flow	-166.78M	-266.77M	-137.58M	-146.53M	-148.46M	-69.69M
Capital Expenditures	-229K	-135K	-1.63M	-1.04M	-328K	-1.04M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-229K	-135K	-1.63M	-1.04M	-328K	-1.04M
Debt Repayment	n/a	59.4M	39.32M	95.45M	42.76M	25M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.93M	1.6M	172.8M	n/a	1.94M	629K
Financial Cash Flow	-288K	182.77M	367.58M	120.04M	44.71M	114.46M
Net Cash Flow	-167.29M	-84.13M	228.37M	-27.87M	-104.08M	43.73M
Free Cash Flow	-166.78M	-266.91M	-139.21M	-147.57M	-148.79M	-70.73M
Adj. Free Cash Flow	-195.49M	-290.95M	-184.24M	-171.7M	-165.6M	-76.57M
Maintenance CapEx	n/a	n/a	n/a	-620K	-328K	-323K
Growth CapEx	-229K	-135K	-1.63M	-421K	n/a	-717K
Owner Earnings	-166.78M	-266.77M	-137.58M	-147.15M	-148.79M	-70.01M